Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial

Annals of Intensive Care

Volumn 8, Issue 1, 2018, Pages

  Demiselle, Julien ^a,b   Wepler, Martin ^c   Hartmann, Clair ^c   Radermacher, Peter ^c   Schortgen, Frédérique ^d   Meziani, Ferhat ^e,f   Singer, Mervyn ^g   Seegers, Valérie ^a   Asfar, Pierre ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^e HÔPITAL CIVIL   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hyperlactatemia; Hyperoxia; Oxygen extraction; Oxygen transport; Sepsis 3; Septic shock

Indexed keywords

CREATININE; EPINEPHRINE; LACTIC ACID; NORADRENALIN; OXYGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; EMERGENCY SURGERY; FEMALE; HOSPITAL INFECTION; HUMAN; HYPERLACTATEMIA; HYPEROXIA; HYPOTENSION; HYPOXEMIA; LACTATE BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RATE; OXYGEN CONCENTRATION; OXYGEN TENSION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE;

EID: 85053467006     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-018-0435-1     Document Type: Article

References (22)

1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10. 10.1001/jama.2016.0287
2. Vincent J-L, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–34. 10.1056/NEJMra1208943
3. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87. 10.1056/NEJMoa067373
4. Russell JA, Lee T, Singer J, et al. The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience. Crit Care Med. 2017;45:940–8. 10.1097/CCM.0000000000002323
5. Asfar P, Schortgen F, Boisramé-Helms J, et al. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med. 2017;5:180–90. 10.1016/S2213-2600(17)30046-2
6. Weil MH, Shubin H. The “VIP” approach to the bedside management of shock. JAMA. 1969;207:337–40
7. Kotani N, Hashimoto H, Sessler DI, et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology. 2000;93:15–25
8. Hafner S, Beloncle F, Koch A, et al. Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update. Ann Intensive Care. 2015. 10.1186/s13613-015-0084-6
9. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg. 1984;119:199–204
10. Waisman D, Brod V, Rahat MA, et al. Dose-related effects of hyperoxia on the lung inflammatory response in septic rats. Shock Augusta Ga. 2012;37:95–102. 10.1097/SHK.0b013e3182356fc3
11. Asfar P, Singer M, Radermacher P. Understanding the benefits and harms of oxygen therapy. Intensive Care Med. 2015;41:1118–21. 10.1007/s00134-015-3670-z
12. Helmerhorst HJF, Schultz MJ, van der Voort PHJ, et al. Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care Lond Engl. 2015;19:284. 10.1186/s13054-015-0996-4
13. de Jonge E, Peelen L, Keijzers PJ, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care Lond Engl. 2008;12:R156. 10.1186/cc7150
14. Helmerhorst HJF, Arts DL, Schultz MJ, et al. Metrics of arterial hyperoxia and associated outcomes in critical care. Crit Care Med. 2017;45:187–95. 10.1097/CCM.0000000000002084
15. Girardis M, Busani S, Damiani E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-icu randomized clinical trial. JAMA. 2016;316:1583. 10.1001/jama.2016.11993
16. Chu DK, Kim LH-Y, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. The Lancet. 2018;391:1693–705. 10.1016/S0140-6736(18)30479-3
17. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:775. 10.1001/jama.2016.0289
18. Dyson A, Simon F, Seifritz A, et al. Bladder tissue oxygen tension monitoring in pigs subjected to a range of cardiorespiratory and pharmacological challenges. Intensive Care Med. 2012;38:1868–76. 10.1007/s00134-012-2712-z
19. Donati A, Damiani E, Zuccari S, et al. Effects of short-term hyperoxia on erythropoietin levels and microcirculation in critically Ill patients: a prospective observational pilot study. BMC Anesthesiol. 2017. 10.1186/s12871-017-0342-2
20. Leverve XM. To cope with oxygen: a long and still tumultuous story for life. Crit Care Med. 2008;36:637–8. 10.1097/CCM.0B013E31816296AD
21. Jamieson D, Chance B, Cadenas E, Boveris A. The relation of free radical production to hyperoxia. Annu Rev Physiol. 1986;48:703–19. 10.1146/annurev.ph.48.030186.003415
22. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet Lond Engl. 2002;360:219–23. 10.1016/S0140-6736(02)09459-X